Vol 2, No 12 (December 08, 2014): Annals of Translational Medicine

Editorial: Diabetes Mellitus

It is time to integrate conventional therapy by ozone therapy in type-2 diabetes patients
Velio Bocci, Iacopo Zanardi, Maya S. P. Huijberts, Valter Travagli
Annals of Translational Medicine
 2014;
2
(12)
:117
Editorial on the original article entitled “Changes in diabetes-related complications in the United States, 1990-2010” published in the New England Journal of Medicine on April 17, 2014
Hala Ahmadieh
Annals of Translational Medicine
 2014;
2
(12)
:118
Measuring the sweet smell of success in diabetes management
Jeff Unger
Annals of Translational Medicine
 2014;
2
(12)
:119
Complications of diabetes: progress, but significant challenges ahead
Tahseen A. Chowdhury, Shang Shaho, Ahmad Moolla
Annals of Translational Medicine
 2014;
2
(12)
:120
A look at the trend in diabetes-related complications in the U.S. over the past two decades: looking ahead
Chee W. Chia, Luigi Ferrucci
Annals of Translational Medicine
 2014;
2
(12)
:121

Review Article

Recent advances in the development of anti-HER2 antibodies and antibody-drug conjugates
Deborah J.L. Wong, Sara A. Hurvitz
Annals of Translational Medicine
 2014;
2
(12)
:122
Clinical advances in the development of novel VEGFR2 inhibitors
Caterina Fontanella, Elena Ongaro, Silvia Bolzonello, Michela Guardascione, Gianpiero Fasola, Giuseppe Aprile
Annals of Translational Medicine
 2014;
2
(12)
:123
Genome-wide association studies in neurology
Meng-Shan Tan, Teng Jiang, Lan Tan, Jin-Tai Yu
Annals of Translational Medicine
 2014;
2
(12)
:124
Application of next-generation sequencing technologies in Neurology
Teng Jiang, Meng-Shan Tan, Lan Tan, Jin-Tai Yu
Annals of Translational Medicine
 2014;
2
(12)
:125

Disclosure:

1. The series “Meet the Professor” was commissioned by the editorial office, Annals of Translational Medicine without any sponsorship or funding.